David Silberman - Net Worth and Insider Trading

David Silberman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Silberman owns 1 companies in total, including Oramed Pharmaceuticals Inc (ORMP) .

Click here to see the complete history of David Silberman’s form 4 insider trades.

Insider Ownership Summary of David Silberman

Ticker Comapny Transaction Date Type of Owner
ORMP Oramed Pharmaceuticals Inc 2022-07-28 Chief Financial Officer

David Silberman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Silberman Ownership Network

Ownership Network List of David Silberman

No Data

Ownership Network Relation of David Silberman

Insider Network Chart

David Silberman Owned Company Details

What does Oramed Pharmaceuticals Inc do?

Who are the key executives at Oramed Pharmaceuticals Inc?

David Silberman is the Chief Financial Officer of Oramed Pharmaceuticals Inc. Other key executives at Oramed Pharmaceuticals Inc include director & 10 percent owner Nadav Kidron , Chief Commercial Officer Michael Rabinowitz , and Chief Legal Officer Netanel Derovan .

Oramed Pharmaceuticals Inc (ORMP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Oramed Pharmaceuticals Inc (ORMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oramed Pharmaceuticals Inc (ORMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Oramed Pharmaceuticals Inc (ORMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oramed Pharmaceuticals Inc Insider Transactions

No Available Data

David Silberman Mailing Address

Above is the net worth, insider trading, and ownership report for David Silberman. You might contact David Silberman via mailing address: 20 Mamilla Avenue, Jerusalem L3 9414904.

Discussions on David Silberman

No discussions yet.